# Preemptive Tapentadol on Post-operative Analgesia Following Total Knee Arthroplasty

> **NCT03351517** · NA · COMPLETED · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 90 (actual)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** Tapentadol 100 MG
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03351517
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2018-08-20
- **Final completion:** 2018-09-07
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2018-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03351517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03351517, "Preemptive Tapentadol on Post-operative Analgesia Following Total Knee Arthroplasty". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03351517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*